New treatment option for schizophrenia – Reagila(R) – listed on PBS this week
– Adults living with schizophrenia will have access to a new treatment option with Reagila(R) (cariprazine) now reimbursed on the Pharmaceutical Benefits Scheme from 1 September, 2021.1 – There continues […]